✦ LIBER ✦

Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms

✍ Scribed by Magnus Ingelman-Sundberg

Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 275 KB
Volume: 369
Category: Article
ISSN: 0028-1298
DOI: 10.1007/s00210-003-0819-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of genes encoding for drug me

Expression of genes encoding for drug metabolising cytochrome P450 enzymes and P-glycoprotein in the rat small intestine; comparison to the liver

✍ Monica Lindell; Matti Lang; Hans Lennernäs 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 983 KB

Cytochrome P450 enzymes in drug metaboli

Cytochrome P450 enzymes in drug metabolism and chemical toxicology: An introduction

✍ Laura Lowe Furge; F. Peter Guengerich 📂 Article 📅 2006 🏛 The American Society for Biochemistry and Molecula 🌐 English ⚖ 446 KB 👁 1 views

Approaches to deorphanization of human a

Approaches to deorphanization of human and microbial cytochrome P450 enzymes

✍ F. Peter Guengerich; Zhongmei Tang; Qian Cheng; S. Giovanna Salamanca-Pinzón 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 674 KB

Inhibition and induction of human cytoch

Inhibition and induction of human cytochrome P450 enzymes: current status

✍ Olavi Pelkonen; Miia Turpeinen; Jukka Hakkola; Paavo Honkakoski; Janne Hukkanen; 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 790 KB

ChemInform Abstract: Roles of Human Cyto

ChemInform Abstract: Roles of Human Cytochrome P450 Enzymes Involved in Drug Metabolism and Toxicological Studies

✍ Hiroshi Yamazaki 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 1 views

In vivo drug metabolism model for human

In vivo drug metabolism model for human cytochrome P450 enzyme using chimeric mice with humanized liver

✍ Miki Katoh; Toshiro Sawada; Yoshinori Soeno; Miki Nakajima; Chise Tateno; Katsut 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

We previously clarified that major human drug metabolizing enzymes were expressed in a chimeric urokinase-type plasminogen activator (uPA)+/+/severe combined immunodeficient (SCID) mouse line established recently, in which the liver could be replaced by more than 80% with human hepatocytes. In the p